Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 236

    1.

    Mutations in the β subunit of RNA polymerase alter intrinsic cephalosporin resistance in Enterococci.

    Kristich CJ, Little JL.

    Antimicrob Agents Chemother. 2012 Apr;56(4):2022-7. Epub 2012 Jan 30.

    PMID:
    22290974
    [PubMed - in process]
    2.

    Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis.

    Warrier T, Tropis M, Werngren J, Diehl A, Gengenbacher M, Schlegel B, Schade M, Oschkinat H, Daffe M, Hoffner S, Eddine AN, Kaufmann SH.

    Antimicrob Agents Chemother. 2012 Apr;56(4):1735-43. Epub 2012 Jan 30.

    PMID:
    22290959
    [PubMed - in process]
    Free PMC Article
    3.

    An antibiotic that inhibits a late step in wall teichoic acid biosynthesis induces the cell wall stress stimulon in Staphylococcus aureus.

    Campbell J, Singh AK, Swoboda JG, Gilmore MS, Wilkinson BJ, Walker S.

    Antimicrob Agents Chemother. 2012 Apr;56(4):1810-20. Epub 2012 Jan 30.

    PMID:
    22290958
    [PubMed - in process]
    4.

    MurAA is required for intrinsic cephalosporin resistance of Enterococcus faecalis.

    Vesić D, Kristich CJ.

    Antimicrob Agents Chemother. 2012 May;56(5):2443-51. Epub 2012 Jan 30.

    PMID:
    22290954
    [PubMed - in process]
    5.

    Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis.

    Pantel A, Petrella S, Veziris N, Brossier F, Bastian S, Jarlier V, Mayer C, Aubry A.

    Antimicrob Agents Chemother. 2012 Apr;56(4):1990-6. Epub 2012 Jan 30.

    PMID:
    22290942
    [PubMed - in process]
    6.

    SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.

    Tahlan K, Wilson R, Kastrinsky DB, Arora K, Nair V, Fischer E, Barnes SW, Walker JR, Alland D, Barry CE 3rd, Boshoff HI.

    Antimicrob Agents Chemother. 2012 Apr;56(4):1797-809. Epub 2012 Jan 17.

    PMID:
    22252828
    [PubMed - in process]
    7.

    A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patients.

    Smythe W, Khandelwal A, Merle C, Rustomjee R, Gninafon M, Bocar Lo M, Sow OB, Olliaro PL, Lienhardt C, Horton J, Smith P, McIlleron H, Simonsson US.

    Antimicrob Agents Chemother. 2012 Apr;56(4):2091-8. Epub 2012 Jan 17.

    PMID:
    22252827
    [PubMed - in process]
    8.

    MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus.

    Seah C, Alexander DC, Louie L, Simor A, Low DE, Longtin J, Melano RG.

    Antimicrob Agents Chemother. 2012 Apr;56(4):1916-20. Epub 2012 Jan 17.

    PMID:
    22252810
    [PubMed - in process]
    9.

    Case-control study comparing de novo and daptomycin-exposed daptomycin-nonsusceptible Enterococcus infections.

    Kelesidis T, Chow AL, Humphries R, Uslan DZ, Pegues D.

    Antimicrob Agents Chemother. 2012 Apr;56(4):2150-2. Epub 2012 Jan 17.

    PMID:
    22252808
    [PubMed - in process]
    10.

    Azole resistance by loss of function of the sterol Δ⁵,⁶-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence.

    Vale-Silva LA, Coste AT, Ischer F, Parker JE, Kelly SL, Pinto E, Sanglard D.

    Antimicrob Agents Chemother. 2012 Apr;56(4):1960-8. Epub 2012 Jan 17.

    PMID:
    22252807
    [PubMed - in process]
    11.

    S279 point mutations in Candida albicans Sterol 14-α demethylase (CYP51) reduce in vitro inhibition by fluconazole.

    Warrilow AG, Mullins JG, Hull CM, Parker JE, Lamb DC, Kelly DE, Kelly SL.

    Antimicrob Agents Chemother. 2012 Apr;56(4):2099-107. Epub 2012 Jan 17.

    PMID:
    22252802
    [PubMed - in process]
    12.

    Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.

    Danby CS, Boikov D, Rautemaa-Richardson R, Sobel JD.

    Antimicrob Agents Chemother. 2012 Mar;56(3):1403-6. Epub 2012 Jan 9.

    PMID:
    22232293
    [PubMed - in process]
    13.

    Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study.

    Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang Y, Wang H, Lu M, So TM, Hsueh PR, Yasin RM, Carlos CC, Pham HV, Lalitha MK, Shimono N, Perera J, Shibl AM, Baek JY, Kang CI, Ko KS, Peck KR; ANSORP Study Group.

    Antimicrob Agents Chemother. 2012 Mar;56(3):1418-26. Epub 2012 Jan 9.

    PMID:
    22232285
    [PubMed - in process]
    14.

    Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.

    Fernandez J, Abbanat D, Shang W, He W, Amsler K, Hastings J, Queenan AM, Melton JL, Barron AM, Flamm RK, Lynch AS.

    Antimicrob Agents Chemother. 2012 Mar;56(3):1476-84. Epub 2012 Jan 9.

    PMID:
    22232278
    [PubMed - in process]
    15.

    Transferable multidrug resistance plasmid carrying cfr associated with tet(L), ant(4')-Ia, and dfrK genes from a clinical methicillin-resistant Staphylococcus aureus ST125 strain.

    Gopegui ER, Juan C, Zamorano L, Pérez JL, Oliver A.

    Antimicrob Agents Chemother. 2012 Apr;56(4):2139-42. Epub 2012 Jan 3.

    PMID:
    22214776
    [PubMed - in process]
    16.

    The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.

    Holmes AR, Keniya MV, Ivnitski-Steele I, Monk BC, Lamping E, Sklar LA, Cannon RD.

    Antimicrob Agents Chemother. 2012 Mar;56(3):1508-15. Epub 2011 Dec 27.

    PMID:
    22203607
    [PubMed - in process]
    17.

    Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.

    Spreghini E, Orlando F, Sanguinetti M, Posteraro B, Giannini D, Manso E, Barchiesi F.

    Antimicrob Agents Chemother. 2012 Mar;56(3):1215-22. Epub 2011 Dec 27.

    PMID:
    22203604
    [PubMed - in process]
    18.

    Reshuffling of Aspergillus fumigatus cell wall components chitin and β-glucan under the influence of caspofungin or nikkomycin Z alone or in combination.

    Verwer PE, van Duijn ML, Tavakol M, Bakker-Woudenberg IA, van de Sande WW.

    Antimicrob Agents Chemother. 2012 Mar;56(3):1595-8. Epub 2011 Dec 27.

    PMID:
    22203603
    [PubMed - in process]
    19.

    First report of the multidrug resistance gene cfr in Enterococcus faecalis of animal origin.

    Liu Y, Wang Y, Wu C, Shen Z, Schwarz S, Du XD, Dai L, Zhang W, Zhang Q, Shen J.

    Antimicrob Agents Chemother. 2012 Mar;56(3):1650-4. Epub 2011 Dec 27.

    PMID:
    22203597
    [PubMed - in process]
    20.

    Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.

    Werngren J, Sturegård E, Juréen P, Ängebyc K, Hoffner S, Schön T.

    Antimicrob Agents Chemother. 2012 Mar;56(3):1253-7. Epub 2011 Dec 27.

    PMID:
    22203587
    [PubMed - in process]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk